Local disposition kinetics of floxuridine after intratumoral and subcutaneous injection as monitored by [19F]-nuclear magnetic resonance spectroscopy in vivo

Cancer Chemotherapy and Pharmacology

Volumn 44, Issue 1, 1999, Pages 65-73

  Port, Ruediger ^a   Hanisch, Friedrich ^a   Becker, Markus ^a   Bachert, Peter ^a   Zeller, Jens ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

19F NMR spectroscopy in vivo; Floxuridine; FUDR; Interstitial application; Tissue pharmacokinetics

Indexed keywords

FLOXURIDINE; FLUOROURACIL;

ANIMAL EXPERIMENT; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG DISPOSITION; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; INTRATUMORAL DRUG ADMINISTRATION; KINETICS; LINEAR SYSTEM; MATHEMATICAL ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; DELAYED-ACTION PREPARATIONS; FEMALE; FLOXURIDINE; FLUORINE; HALF-LIFE; INJECTIONS, SUBCUTANEOUS; KINETICS; LIVER NEOPLASMS; MAGNETIC RESONANCE SPECTROSCOPY; RATS; TISSUE DISTRIBUTION;

EID: 0033022085     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050946     Document Type: Article

References (54)

1. Arellano M, Cabanac-Longo S, Malet-Martino M, Martino R (1994) Fluorine-19 NMR is a powerful tool for discriminating the anabolites of the anticancer drug 5-fluorouracil In: Book of abstracts, 2nd annual scientific meeting of the Society of Magnetic Resonance. Society of Magnetic Resonance, Berkeley, p 1355
2. 13C labeled anticancer agent temozolomide detected in vivo by selective cross-polarization transfer. Magn Reson Med 34: 338-342
3. Au JLS, Walker JS, Rustum Y (1983) Pharmacokinetic studies of 5-flourouracil and 5'-deoxy-5-fluorouridine in rats. J Pharmacol Exp Ther 227: 174-180
4. Bachert P (1998) Pharmacokinetics using fluorine NMR in vivo. Prog Nucl Magn Reson Spectrosc 33: 1-56
5. 19F MR spectroscopy. J Neural Transm Gen Sect 99: 1-6
6. Bartolozzi C, Lencioni R (1996) Ethanol injection for the treatment of hepatic tumors. Eur Radiol 6: 682-696
7. Beal SL, Sheiner LB (eds) (1992) NONMEM User's guides. NONMEM Project Group. University of San Francisco, San Francisco
8. 195Pt NMR. J Magn Reson 133: 115-122
9. Benet LZ (1972) General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics. J Pharm Sci 61: 536-541
10. 19F MR imaging. Magn Reson Med 34: 302-307
11. Brockmeier D, Ostrowski J (1985) Mean time and first-pass metabolism. Eur J Clin Pharmacol 29: 45-58
12. Buahin KG, Brem H (1995) Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release. J Neurooncol 26: 103-110
13. 2H-Nuclear magnetic resonance imaging of tumor blood flow: spatial and temporal heterogeneity in a tissue-isolated mammary adenocarcinoma. Cancer Res 52: 6010-6019
14. Eskey CJ, Wolmark N, McDowell CL, Domach MM, Jain RK (1994) Residence time distributions of various tracers in tumors: implications for drug delivery and blood flow measurement. J Natl Cancer Inst 86: 293-299
15. Findlay MPN, Leach MO (1994) In vivo monitoring of fluoropyrimidine metabolities: magnetic resonance spectroscopy in the evaluation of 5-fluorouracil.. Anticancer Res 5: 260-280
16. Gyulai L, Wicklund SW, Greenstein R, Bauer MS, Ciccione P, Whybrow PC, Zimmerman J, Kovachich G, Alves W (1991) Measurement of tissue lithium concentration by lithium magnetic resonance spectroscopy in patients with bipolar disorder. Biol Psychiatry 29: 1161-1170
17. 31P NMR and in vitro uptake experiments. Magn Reson Med 39: 754-761
18. Hamberg LM, Kristjansen PEG, Hunter GJ, Wolf GL, Jain RK (1994) Spatial heterogeneity in tumor perfusion measured with functional computed tomography at 0.05 μ1 resolution. Cancer Res 54: 6032-6036
19. Hashida M, Kato A, Kojima T, Muranishi S, Sezaki H, Tanigawa N, Satomura K, Hikasa Y (1981) Antitumor activity of mitomycin C-dextran conjugate against various murine tumors. Gann 72: 226-234
20. He Q, Bhujwalla ZM, Maxwell RJ, Griffiths JR, Glickson JD (1995) Proton NMR observation of the antineoplastic agent iproplatin in vivo by selective multiple quantum coherence transfer (Sel-MQC). Magn Reson Med 33: 414-416
21. Jain RK (1994) Barriers to drug delivery in solid tumors. Sci Am July: 42-49
22. Jain RK (1996) 1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors. Ann Biomed Eng 24:457-473
23. Jynge P, Skjetne T, Gribbestad I, Kleinbloesem CH, Hoogkamer HFW, Antonsen O, Krane J, BakØy OE, Furuheim KM, Nilsen OG (1990) In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans. Clin Pharmacol Ther 48: 481-489
24. Knepp WA, Jayakrishnan A, Quigg JM, Sitren HS, Bagnall JJ, Goldberg EP (1993) Synthesis, properties, and intratumoral evaluation of mitoxantrone-loaded casein microspheres in Lewis lung carcinoma. J Pharm Pharmacol 45: 887-891
25. 7Li nuclear magnetic resonance study of lithium pharmacokinetics and chemical shift imaging in psychiatric patients. Psychiatry Res 50: 67-76
26. 19F-magnetic resonance spectroscopy and cytostatic in vivo activity of gemcitabine (dFdC) in two small cell lung cancer xenografts. Ann Oncol 4: 157-160
27. Kuang L, Yang DJ, Inoue T, Liu WC, Wallace S, Wright KC (1996) Percutaneous intratumoral injection of cisplatin microspheres in tumor-bearing rats to diminish acute nephrotoxicity. Anticancer Drugs 7: 220-227
28. Landrito JE, Yoshiga K, Sakurai K, Takada K (1994) Effects of intralesional injection of cisplatin dissolved in urografin and lipiodol on Ehrlich ascites tumor and normal tissues of CD-1 mice. Cancer Chemother Pharmacol 34: 323-330
29. Landrito JE, Yoshiga K, Sakurai K, Takada K (1994) Effects of intralesional injection of cisplatin on squamous cell carcinoma and normal tissue of mice. Anticancer Res 1: 113-118
30. Lockwood CG, Dob DP, Bryant DJ, Wilson JA, Sargentoni J, Sapsed-Byrne SM, Harris DN, Menon DK (1997) Magnetic resonance spectroscopy of isoflurane kinetics in humans.I. Elimination from the head. Br J Anaesth 79: 581-585
31. Lockwood CG, Dob DP, Bryant DJ, Wilson JA, Sargentoni J, Sapsed-Byrne SM, Harris DN, Menon DK (1997) Magnetic resonance spectroscopy of isoflurane kinetics in humans. II. Functional localization. Br J Anaesth 79: 586-589
32. Malet-Martino M-C, Martino R (1991) Uses and limitations of nuclear magnetic resonance (NMR) spectroscopy in clinical pharmacokinetics. Clin Pharmacokinet 20: 337-349
33. Maxwell RJ (1993) New techniques in the pharmacokinetic analysis of cancer drugs. III. Nuclear magnetic resonance. Cancer Surv 17: 415-423
34. 19F-Nuclear magnetic resonance imaging of drug distribution in vivo: the disposition of an antifolate anticancer drug in mice. Magn Reson Med 17: 189-196
35. Menei P, Boisdron-Celle M, Croue A, Guy G, Benoit JP (1996) Effect of stereotactic implantation of biodegradable 5-fluorouracil loaded microspheres in healthy and C6 glioma-bearing rats. Neurosurgery 39: 117-124
36. Miller BH, Shavin JS, Cognetta A, Taylor RJ, Salasche S, Korey A, Orenberg EK, (1997) Nonsurgical treatment of basal cell carcinoma with intralesional 5-fluorouracil/epinephrine injected gel. J Am Acad Dermatol 36: 72-77
37. Nakashima E, Benet LZ (1988) General treatment of mean residence time, clearance, and volume parameters in linear mammillary models with elimination from any compartment. J Pharmacokinet Biopharm 16: 475-492
38. National Institute for Occupational Health and Safety (NIOSH) (1998) Registry of toxic effects of chemical substances (RTECS). NIOSH, Fredericksburg, Maryland
39. 19F-NMR spectroscopy. Br J Cancer 62: 766-772
40. Newell DR, Maxwell RJ, Golding BT (1992) In vivo and ex vivo magnetic resonance spectroscopy as applied to pharmacokinetic studies with anticancer agents: a review. NMR Biomed 5: 273-278
41. Penn RD, Kroin JS, Harris JE, Chiu KM, Braun DP (1983) Chronic intratumoral chemotherapy of a rat tumor with cisplatin and fluorouracil. Appl Neurophysiol 46: 240-244
42. Port RE, Knopp MV, Hoffmann U, Zabel S, Brix G (1996) Pharmacokinetics of gadolinium DTPA in arterial blood and in malignant and benign mammary tumors, monitered simulataneously by dynamic NMR tomography. In: Kuhlmann J, Klotz U (eds) Clinical pharmacology and oncology (Clinical pharmacology, vol 14) W. Zuckschwerdt, Munich, pp 82-88
43. 31P-MRS in rat tumours: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas. Br J Cancer 75: 62-68
44. Rowland M, Tozer TN (1995) Clinical pharmacokinetics: concepts and applications, 3rd ed. Williams & Wilkins. Baltimore, p 486
45. Sachs GS, Renshaw PF, Lafer B, Stoll AL, Guimaraes AR, Rosenbaum JF, Gonzalez RG (1995) Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study. Biol Psychiatry 38: 422-428
46. Saikawa A, Nomura T, Yamashita F, Takakura Y, Sezaki H, Hashida M (1996) Pharmacokinetic analysis of drug disposition after intratumoral injection in a tissue-isolated tumor perfusion system. Pharm Res 13: 1438-1444
47. Smith JP, Stock E, Orenberg EK, Yu NY, Kanekal S, Brown DM (1995) Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of human pancreatic cancer xenografts. Anticancer Drugs 6: 717-726
48. Statistical Sciences Inc. (1992) S-Plus, version 3.1. Statistical Sciences Inc., Seattle
49. Tomita T (1991) Interstitial chemotherapy for brain tumors: review. J Neuro-oncol 10: 57-74
50. Walter KA, Tamargo RJ, Olivi A, Burger PC, Brem H (1995) Intratumoral chemotherapy. Neuro-surgery 37: 1128-1145
51. Weber G, Queener SF, Ferdinandus JA (1971) Control of gene expression in carbohydrate, pyrimidine and DNA metabolism. Adv Enzyme Regul 9: 63-95
52. Williams WM, Huang KC, Chen TS, Warren BS (1987) Dose-dependent elimination of 5-fluoro-2'-deoxyuridine in the monkey (42487). Proc Soc Exp Biol Med 184: 326-336
53. 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits. Proc Natl Acad Sci USA 87: 492-496
54. 19F-magnetic resonance spectroscopy to evaluate tumoral pharmacokinetics of AccuSite (fluorouracil/epinephrine) injectable gel for treatment of human basal cell carcinoma. Proc Am Assoc Cancer Res 36: 365